
Фармсинтез LIFE
Фармсинтез Accumulated Other Comprehensive Income Loss 2007-2025 | LIFE
Annual Accumulated Other Comprehensive Income Loss Фармсинтез
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -634 M | -663 M | -779 M | -338 M | -521 M | -486 M | -454 M | -412 M | -372 M | -338 M | - | -157 M | - | -123 M | -104 M |
All numbers in RUB currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -104 M | -779 M | -414 M |
Quarterly Accumulated Other Comprehensive Income Loss Фармсинтез
| 2023-Q2 | 2022-Q4 | 2022-Q2 | 2021-Q4 | 2021-Q2 | 2020-Q4 | 2020-Q2 | 2019-Q4 | 2019-Q2 | 2018-Q4 | 2018-Q2 | 2017-Q4 | 2017-Q2 | 2016-Q4 | 2016-Q2 | 2015-Q4 | 2015-Q2 | 2014-Q4 | 2014-Q2 | 2013-Q4 | 2013-Q2 | 2012-Q4 | 2011-Q4 | 2011-Q2 | 2010-Q4 | 2010-Q2 | 2009-Q4 | 2009-Q2 | 2008-Q4 | 2008-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -469 K | -568 M | -634 M | -678 M | -663 M | -689 M | -779 M | -345 M | -313 M | 189 M | -521 M | - | -486 M | 295 M | -454 M | 173 M | 396 M | -390 M | 8.21 M | -342 M | -338 M | - | -78.6 M | -157 M | -78.6 M | - | -61.4 M | -123 M | -114 M |
All numbers in RUB currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 396 M | -779 M | -260 M |